- Home
- RGC vs EARN Comparison
RGC vs EARN Comparison
Compare RGC & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGC | EARN |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8B | 200.3M |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | RGC | EARN |
|---|---|---|
| Price | $22.26 | $5.33 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.88 |
| AVG Volume (30 Days) | ★ 325.6K | 312.5K |
| Earning Date | 10-24-2025 | 02-20-2026 |
| Dividend Yield | N/A | ★ 18.11% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,893,000.00 |
| Revenue This Year | N/A | $8.43 |
| Revenue Next Year | N/A | $17.27 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 43.30 |
| 52 Week Low | $0.09 | $4.33 |
| 52 Week High | $83.60 | $6.86 |
Technical Indicators
Market Signals| Indicator | RGC | EARN |
|---|---|---|
| Relative Strength Index (RSI) | 62.05 | 54.31 |
| Support Level | $19.80 | $5.15 |
| Resistance Level | $25.50 | $5.40 |
| Average True Range (ATR) | 2.51 | 0.09 |
| MACD | 0.52 | 0.01 |
| Stochastic Oscillator | 59.72 | 75.00 |
Price Performance
Historical ComparisonAbout RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
About EARN Ellington Residential Mortgage REIT of Beneficial Interest
Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.